Atherosclerotic renovascular disease

Canadian Journal of Cardiology

Volumn 22, Issue 7, 2006, Pages 623-628

  Tobe, Sheldon W ^a,d   Burgess, Ellen ^b   Lebel, Marcel ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d NONE   (Canada)

Author keywords

Hypertension; Kidney disease; Renal artery stenosis; Renovascular disease; Resistant hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; THIAZIDE DIURETIC AGENT;

ALGORITHM; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; DYSLIPIDEMIA; ENDOVASCULAR SURGERY; EVIDENCE BASED MEDICINE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; MAGNETIC RESONANCE ANGIOGRAPHY; MICROANGIOPATHY; NEPHROSCLEROSIS; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; PREVALENCE; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; REVASCULARIZATION; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SMOKING; SODIUM RETENTION; STENT; SURVIVAL; VASOCONSTRICTION; ATHEROSCLEROSIS; DECISION MAKING; DIAGNOSTIC IMAGING; KIDNEY; KIDNEY CIRCULATION; KIDNEY FUNCTION TEST; PATHOLOGY; REVIEW;

ATHEROSCLEROSIS; DECISION MAKING; DIAGNOSTIC IMAGING; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FUNCTION TESTS; PREVALENCE; PROGNOSIS; RENAL ARTERY OBSTRUCTION; RENAL CIRCULATION;

EID: 33745699524     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(06)70286-0     Document Type: Article

References (35)

1. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol 2002;13:959-74.
2. Pickering TG, Blumenfeld JD. Renovascular hypertension and ischemic nephropathy. In: Brenner BM, ed. Brenner and Rector's The Kidney. Philadelphia: WB Saunders Co, 2000:2007-34.
3. Textor SC, Tarazi RC, Novick AC, Bravo EL, Fouad FM. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril. Am J Med 1984;76:29-37.
4. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: A population-based study. J Vasc Surg 2002;36:443-51.
5. Tanemoto M, Saitoh H, Satoh F, et al. Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis. Hypertens Res 2005;28:237-42.
6. van Jaarsveld BC, Krijnen P, Derkx FH, et al. Resistance to antihypertensive medication as predictor of renal artery stenosis: Comparison of two drug regimens. J Hum Hypertens 2001;15:669-76.
7. Uzu T, Takeji M, Yamada N, et al. Prevalence and outcome of renal artery stenosis in atherosclerotic patients with renal dysfunction. Hypertens Res 2002;25:537-42.
8. Kuroda S, Nishida N, Uzu T, et al. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke 2000;31:61-5.
9. Cohen MG, Pascua JA, Garcia-Ben M, et al. A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 2005;150:1204-11.
10. Radermacher J, Chavan A, Schaffer J, et al. Detection of significant renal artery stenosis with color Doppler sonography: Combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol 2000;53:333-43.
11. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344:410-7.
12. Vasbinder GB, Nelemans PJ, Kessels AG, et al, Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004;141:674-82.
13. Mittal BR, Kumar P, Arora P, et al. Role of captopril renography in the diagnosis of renovascular hypertension. Am J Kidney Dis 1996;28:209-13.
14. Lin CC, Shiau YC, Li TC, et al. Usefulness of captopril renography to predict the benefits of renal artery revascularization or captopril treatment in hypertensive patients with diabetic nephropathy. J Diabetes Complications 2002;16:344-6.
15. Gunay EC, Ozturk MH, Ergun EL, et al. Losartan renography for the detection of renal artery stenosis: Comparison with captopril renography and evaluation of dose and timing. Eur J Nucl Med Mol Imaging 2005;32:1064-74.
16. Taylor A. Functional testing: ACEI renography. Sem Nephrol 2000;20:437-44.
17. Radermacher J, Chavan A, Schaffer J, et al. Detection of significant renal artery stenosis with color Doppler sonography: Combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol 2000;53:333-43.
18. Radermacher J, Haller H. The right diagnostic work-up: Investigating renal and renovascular disorders. J Hypertens 2003;21(Suppl 2):S19-24.
19. Lenz T, Kia T, Rupprecht G, et al. Captopril test: Time over? J Hum Hypertens 1999;13:431-5.
20. Wright JR, Shurrab AE, Cheung C, et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002;39:1153-61.
21. Losito A, Errico R, Santirosi P, et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant 2005;20:1604-9.
22. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866-72.
23. Fernandez F, Morel D, Jeandot R, et al. Value of captopril renal scintigraphy in hypertensive patients with renal failure. J Nucl Med 1999;40:412-7.
24. Fommei E, Ghione S, Hilson AJ, et al. Captopril radionuclide test in renovascular hypertension: A European multicentre study. European Multicentre Study Group. Eur J Nucl Med 1993;20:617-23.
25. Mackrell PJ, Langan EM, III, Sullivan TM, et al. Management of renal artery stenosis: Effects of a shift from surgical to percutaneous therapy on indications and outcomes. Ann Vasc Surg 2003;17:54-9.
26. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342:1007-14.
27. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31:823-9.
28. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial. Lancet 1999;353:282-6.
29. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003;114:44-50.
30. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: Where do we stand? A meta-analysis. Radiology 2000;216:78-85.
31. Textor SC, Wilcox CS. Renal artery stenosis: A common, treatable cause of renal failure? Ann Rev Med 2001;52:421-42.
32. Bolduc JP, Oliva VL, Therasse E, et al. Diagnosis and treatment of renovascular hypertension: A cost-benefit analysis. AJR Am J Roentgenol 2005;184:931-7.
33. Bax L, Mali WP, Buskens E, et al. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: Rationale and study design. J Nephrol 2003;16:807-12.
34. Clinical Trials. Benefits of medical therapy plus stenting for renal atherosclerotic lesions. Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). (Version current at May 10, 2006).
35. Clinical Trials. Renal Atherosclerotic Revascularization Evaluation: RAVE study. www.clinicaltrials.gov/ct/show/NCT00127738?order=1> (Version current at May 10, 2006).